Emmanuel Raffoux

10PUBLICATIONS
79CO-AUTHORS
Molecular targetsLiquid biopsiesMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 08, 2026
Splicing-associated network PAK1-CLK1/4-SRRM1 is a vulnerability to overcome chemoresistance in human and mouse acute myeloid leukemia.

|May 12, 2026
Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement.

|Mar 27, 2026
Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemia.

Loïc Vasseur, Matthieu Duchmann, Nicolas Duployez

|Jul 07, 2025
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms.

Nabih Maslah, Nina Kaci, Blandine Roux

|Jun 24, 2025
Comparison of induction with arsenic trioxide or chemotherapy in a real-world cohort of patients with high-risk acute promyelocytic leukemia.

Delphine Lebon, Audrey Da Rocha, Bruno Cassinat

|Jun 11, 2025
AML patient blasts exhibit polarization defects upon interaction with bone marrow stromal cells.

Khansa Saadallah, Benoît Vianay, Louise Bonnemay

Pageof 2

Frequent Collaborators

6 joint publications

Raphaël Itzykson

5 joint publications

Nicolas Duployez

5 joint publications

Lionel Adès

4 joint publications

Delphine Lebon